Hexagon Nutrition IPO GMP Today, Price & Details
Hexagon Nutrition IPO GMP Today, Price Band, Subscription Status, Allotment & Listing Details
About Hexagon Nutrition
Hexagon Nutrition works in the clinical and public-health nutrition space, making micronutrient premixes, food-fortification blends, and medical-nutrition products. It's a business with a genuine social-impact angle — fortifying staple foods and supplying nutrition programmes — alongside a commercial medical-nutrition arm. The IPO was a mainboard offering on the NSE, sized at ₹138.87 Cr and priced at ₹42–45 per share with a low face value of ₹1.
On the financials, the company reported revenue of ₹267.59 Cr and net profit of ₹27.03 Cr, with a steady EBITDA margin of 12.33% and reasonable return ratios of 12.46% RONW and 17.06% ROCE. It's a moderately profitable, specialised nutrition player rather than a high-flyer.
This was a 100% offer for sale of ₹138.87 Cr, so the money went to existing shareholders rather than into the company. For investors, that means no fresh growth capital — you're buying a stake in an established, niche business at its current run-rate.
Hexagon Nutrition IPO — Investment Analysis
At the upper band of ₹45, Hexagon was valued at 14.33x earnings on an EPS of ₹2.93 — a modest, undemanding multiple that stood out as one of the more reasonably priced offerings of the season. That value pricing was likely a big reason for the strong response.
The financial profile is steady rather than spectacular. A 12.33% EBITDA margin and 17.06% ROCE are respectable for a nutrition-products business, and revenue of ₹267.59 Cr gives it decent scale. The specialised, regulated nature of medical nutrition also provides a modest moat.
On the risk side, the 100% OFS structure means no fresh capital for expansion, and a chunk of the business depends on government and institutional nutrition programmes, which can be tender-driven and lumpy. Raw-material costs and regulatory approvals in the food-and-nutrition space are the other watch-items.
The market liked the value on offer. The issue was subscribed 161.49x overall, led by NII at 161.49x, with QIB at 19.77x and retail a strong 26.85x — and the stock duly listed with a healthy gain, opening at ₹48 against the ₹45 issue price. Our IPO profit calculator can size the per-lot returns. Investors should consult a SEBI-registered financial advisor before making investment decisions.
Disclaimer: This analysis is auto-generated from publicly available financial data and should not be considered investment advice. Always consult a SEBI-registered financial advisor before making investment decisions.
Hexagon Nutrition IPO — Pros & Cons
Strengths
- An attractive, undemanding valuation at 14.33x earnings — one of the cheaper mainboard offerings of the season, leaving room for upside.
- A specialised niche in clinical nutrition and food fortification, which brings regulatory barriers and a modest social-impact moat.
- Steady profitability, with a 12.33% EBITDA margin and 17.06% ROCE that are solid for the nutrition space.
- Strong, broad-based demand, with the issue subscribed 161.49x overall across NII, QIB and retail.
- A healthy listing, with shares opening at ₹48 versus the ₹45 issue price — a 6.7% gain that rewarded allottees.
Risks
- A 100% offer for sale means none of the ₹138.87 Cr reached the company — there's no fresh capital to fund expansion.
- Dependence on government and institutional nutrition programmes can make revenue tender-driven and lumpy from year to year.
- Only moderate return ratios, with RONW of 12.46% — decent but not the standout numbers seen in some peers.
- Raw-material cost swings and food-nutrition regulatory approvals add operational risk to a specialised business.
- With the issue 161x oversubscribed, retail allotment was unlikely for most small applicants.
Hexagon Nutrition IPO Details
| Company Name | Hexagon Nutrition |
|---|---|
| IPO Type | MAINBOARD |
| Exchange | NSE |
| Price Band | ₹42 - ₹45 |
| Face Value | ₹1 per share |
| Lot Size | 333 shares |
| Min Investment | ₹14,985 |
| Total Issue Size | ₹138.87 Cr |
|---|---|
| Offer for Sale | ₹138.87 Cr |
| Registrar | Kfin Technologies Ltd. |
| Lead Manager | List of Issues managed, Cumulative Capital Pvt.Ltd., Catalyst Capital Partners Pvt.Ltd. |
| IPO Status | Listed |
Hexagon Nutrition IPO Dates
Hexagon Nutrition IPO Listing Performance
Hexagon Nutrition IPO listed on NSE on 12 Jun 2026 at ₹48, a premium of 6.7% over the issue price of ₹45. Investors who received allotment made a profit of ₹999 per lot (333 shares) on listing day.
Hexagon Nutrition IPO — Key Highlights
- Clinical-nutrition and food-fortification firm, IPO of ₹138.87 Cr.
- Attractively valued at 14.33x earnings on an EPS of ₹2.93.
- Subscribed 161.49x overall — strong across categories.
- Listed at ₹48 versus ₹45 — a 6.7% gain.
- Entirely a 100% offer for sale of ₹138.87 Cr.
- Steady 12.33% EBITDA margin and 17.06% ROCE.
Hexagon Nutrition Financial Performance
| Metric (₹ Cr) | FY 2023 | FY 2024 | FY 2025 | 9M FY 2026 |
|---|---|---|---|---|
| Revenue | 278.50 | 297.73 | 324.93 | 267.59 |
| Expenses | 267.02 | 285.48 | 296.78 | 239.83 |
| Net Income (PAT) | 5.82 | 12.21 | 24.38 | 27.03 |
| Margin (%) | 2.10% | 4.10% | 7.50% | 10.10% |
Hexagon Nutrition IPO Valuations & Key Metrics
Valuation Ratios
| EPS | ₹2.93 |
|---|---|
| P/E Ratio | 14.33x |
| NAV | ₹15.91 |
| Current Ratio | 8,211.00 |
| Debt/Equity | 0.140 |
Return Metrics
| RONW (%) | 12.46% |
|---|---|
| ROCE (%) | 17.06% |
| EBITDA Margin | 12.33% |
| Employees | 527 |
Hexagon Nutrition IPO Reservation / Allocation
Hexagon Nutrition IPO Anchor Investors
| Bid Date | 4 June 2026 |
|---|---|
| Shares Offered | 92,57,696 shares |
| Anchor Portion (INR Cr.) | INR 41.66 crore |
| Anchor lock-in period end date for 50% shares (30 Days) | 6 July 2026 |
| Anchor lock-in period end date for remaining shares (90 Days) | 3 September 2026 |
Hexagon Nutrition IPO Peer Comparison
| Company | PE ratio | EPS | RONW (%) | NAV | Revenue (Cr.) |
|---|---|---|---|---|---|
| Hexagon Nutrition | 25.71 | 1.75 | 12.46 | 15.91 | 324.93 |
| Zydus Wellness | 46.22 | 10.90 | 6.12 | 178.26 | 2,780.90 |
| Nestle India | 88.86 | 16.63 | 77.91 | 21.35 | 20,201.56 |
Hexagon Nutrition IPO Lead Manager & Registrar
Book Running Lead Manager
List of Issues managed, Cumulative Capital Pvt.Ltd., Catalyst Capital Partners Pvt.Ltd.
IPO Registrar
Kfin Technologies Ltd.
Hexagon Nutrition IPO — Frequently Asked Questions
What is Hexagon Nutrition IPO GMP today?
As of today, the Grey Market Premium (GMP) for Hexagon Nutrition IPO is ₹9 per share, indicating a potential listing premium of 20% above the issue price of ₹45.
What is the price band and lot size of Hexagon Nutrition IPO?
Hexagon Nutrition IPO has a price band of ₹42 to ₹45 per equity share with a face value of ₹1. The minimum lot size is 333 shares, requiring a minimum investment of ₹14,985 at the upper band.
What are the important dates for Hexagon Nutrition IPO?
Hexagon Nutrition IPO opens for subscription on 05 Jun 2026 and closes on 09 Jun 2026. Allotment is expected on 10 Jun 2026. The shares are expected to list on NSE on 12 Jun 2026.
What is the investor category allocation in Hexagon Nutrition IPO?
The shares are reserved as follows — Qualified Institutional Buyers (QIB): 50.00%, Non-Institutional Investors (NII/HNI): 15.00%, and Retail Individual Investors: 35.00%.
How can I apply for Hexagon Nutrition IPO?
You can apply for Hexagon Nutrition IPO through your bank's net banking ASBA facility or via UPI-based application through any stockbroker platform. Ensure you have sufficient funds in your bank account as the amount will be blocked until allotment. The registrar for this IPO is Kfin Technologies Ltd..
What was Hexagon Nutrition IPO's price band and lot size?
Hexagon Nutrition was priced at ₹42 to ₹45 per share, with a lot of 333 shares. At the upper band the minimum retail investment came to about ₹14,985, and the face value was ₹1.
What does Hexagon Nutrition do?
It makes micronutrient premixes, food-fortification blends, and medical-nutrition products — serving both public-health nutrition programmes and a commercial clinical-nutrition market.
How did Hexagon Nutrition perform on listing?
Well — after a strong 161.49x subscription, the stock opened at ₹48 against its ₹45 issue price, a listing gain of about 6.7%.
Was Hexagon Nutrition IPO fairly valued?
Yes — at 14.33x earnings it was one of the more reasonably priced mainboard offerings of the season, which helped drive the strong demand.